BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Iacob DG, Rosca A, Ruta SM. Circulating microRNAs as non-invasive biomarkers for hepatitis B virus liver fibrosis. World J Gastroenterol 2020; 26(11): 1113-1127 [PMID: 32231417 DOI: 10.3748/wjg.v26.i11.1113]
URL: https://www.wjgnet.com/1007-9327/full/v26/i11/1113.htm
Number Citing Articles
1
Cao Deping, Jiang Bofan, Zhang Yaogang, Pang Mingquan. microRNA-125b-5p is a promising novel plasma biomarker for alveolar echinococcosis in patients from the southern province of QinghaiBMC Infectious Diseases 2021; 21(1) doi: 10.1186/s12879-021-05940-z
2
Catherine Jane Messner, Saskia Schmidt, Dilek Özkul, Carine Gaiser, Luigi Terracciano, Stephan Krähenbühl, Laura Suter-Dick. Identification of miR-199a-5p, miR-214-3p and miR-99b-5p as Fibrosis-Specific Extracellular Biomarkers and Promoters of HSC ActivationInternational Journal of Molecular Sciences 2021; 22(18): 9799 doi: 10.3390/ijms22189799
3
Verdiana Zulian, Giulia Fiscon, Paola Paci, Anna Rosa Garbuglia. Hepatitis B Virus and microRNAs: A Bioinformatics ApproachInternational Journal of Molecular Sciences 2023; 24(24): 17224 doi: 10.3390/ijms242417224
4
Mirza Ali Nazarnezhad, Mahdi Barazesh, Soudabeh Kavousipour, Shiva Mohammadi, Ebrahim Eftekhar, Sajad Jalili. The Computational Analysis of Single Nucleotide Associated with MicroRNA Affecting Hepatitis B InfectionMicroRNA 2022; 11(2): 139 doi: 10.2174/2211536611666220509103724
5
Yiwei Wang, Yanling Li, Xinyu Liang, Shuyu Xin, Li Yang, Pengfei Cao, Mingjuan Jiang, Yujie Xin, Senmiao Zhang, Yang Yang, Jianhong Lu. The implications of cell‐free DNAs derived from tumor viruses as biomarkers of associated cancersJournal of Medical Virology 2022; 94(10): 4677 doi: 10.1002/jmv.27903
6
Yuanyuan Ren, Lei Yang, Man Li, Jian Wang, Huimin Yan, Ning Ma, Wenxuan Liu, Liqin Wang, Xia Gao, Ping Gao, Tao Li, Dianwu Liu. 4210 Da and 1866 Da polypeptides as potential biomarkers of liver disease progression in hepatitis B virus patientsScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-96581-4
7
Amin Ullah, Irshad Ur Rehman, Katharina Ommer, Nadeem Ahmed, Margarete Odenthal, Xiaojie Yu, Jamshaid Ahmad, Tariq Nadeem, Qurban Ali, Bashir Ahmad. Circulating miRNA-192 and miR-29a as Disease Progression Biomarkers in Hepatitis C Patients with a Prevalence of HCV Genotype 3Genes 2023; 14(5): 1056 doi: 10.3390/genes14051056
8
Alicia Vachon, Carla Osiowy. Novel Biomarkers of Hepatitis B Virus and Their Use in Chronic Hepatitis B Patient ManagementViruses 2021; 13(6): 951 doi: 10.3390/v13060951
9
Simona Ruta, Laura Grecu, Diana Iacob, Costin Cernescu, Camelia Sultana. HIV-HBV Coinfection—Current Challenges for Virologic MonitoringBiomedicines 2023; 11(5): 1306 doi: 10.3390/biomedicines11051306
10
Chinmay Bera, Nashla Hamdan-Perez, Keyur Patel. Non-Invasive Assessment of Liver Fibrosis in Hepatitis B PatientsJournal of Clinical Medicine 2024; 13(4): 1046 doi: 10.3390/jcm13041046
11
Tomoko Tadokoro, Asahiro Morishita, Tsutomu Masaki. Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNAInternational Journal of Molecular Sciences 2021; 22(15): 8139 doi: 10.3390/ijms22158139
12
Xia Zhou, Ziyu Liang, Shanyu Qin, Xianxian Ruan, Haixing Jiang. Serum-derived miR-574-5p-containing exosomes contribute to liver fibrosis by activating hepatic stellate cellsMolecular Biology Reports 2022; 49(3): 1945 doi: 10.1007/s11033-021-07008-2
13
Erika Cione, Diana Marisol Abrego Guandique, Maria Cristina Caroleo, Filippo Luciani, Manuela Colosimo, Roberto Cannataro. Liver Damage and microRNAs: An UpdateCurrent Issues in Molecular Biology 2022; 45(1): 78 doi: 10.3390/cimb45010006
14
Yi-Jie Li, Brittney O Baumert, Nikos Stratakis, Jesse A Goodrich, Hao-Tian Wu, Jing-Xuan He, Yin-Qi Zhao, Max T Aung, Hong-Xu Wang, Sandrah P Eckel, Douglas I Walker, Damaskini Valvi, Michele A La Merrill, Justin R Ryder, Thomas H Inge, Todd Jenkins, Stephanie Sisley, Rohit Kohli, Stavra A Xanthakos, Andrea A Baccarelli, Rob McConnell, David V Conti, Lida Chatzi. Circulating microRNA expression and nonalcoholic fatty liver disease in adolescents with severe obesityWorld Journal of Gastroenterology 2024; 30(4): 332-345 doi: 10.3748/wjg.v30.i4.332
15
Elissa Bardhi, Jennifer McDaniels, Thomas Rousselle, Daniel G. Maluf, Valeria R. Mas. Nucleic acid biomarkers to assess graft injury after liver transplantationJHEP Reports 2022; 4(3): 100439 doi: 10.1016/j.jhepr.2022.100439
16
Asahiro Morishita, Kyoko Oura, Tomoko Tadokoro, Koji Fujita, Joji Tani, Hideki Kobara, Masafumi Ono, Takashi Himoto, Tsutomu Masaki. MicroRNAs and Nonalcoholic Steatohepatitis: A ReviewInternational Journal of Molecular Sciences 2023; 24(19): 14482 doi: 10.3390/ijms241914482
17
Verdiana Zulian, Giulia Fiscon, Paola Paci, Anna Rosa Garbuglia. Overview of bioinformatic tools to study viral infections2023 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) 2023; : 3669 doi: 10.1109/BIBM58861.2023.10385909
18
Mohamed H.A. Aboshanab, Mohamed A. El-Nabarawi, Mahmoud H. Teaima, Aziza A. El-Nekeety, Sekena H. Abdel-Aziem, Nabila S. Hassan, Mosaad A. Abdel-Wahhab. Fabrication, characterization and biological evaluation of silymarin nanoparticles against carbon tetrachloride-induced oxidative stress and genotoxicity in ratsInternational Journal of Pharmaceutics 2020; 587: 119639 doi: 10.1016/j.ijpharm.2020.119639
19
Marina Manea, Dimitri Apostol, Ileana Constantinescu. A MicroRNA-Based Method for High-Viremia Detection—A New Approach on a Romanian Lot of Chronically Infected Patients with Hepatitis B VirusDiagnostics 2023; 13(22): 3425 doi: 10.3390/diagnostics13223425
20
Long-Yuan Zhou, Si-Nan Lin, Florian Rieder, Min-Hu Chen, Sheng-Hong Zhang, Ren Mao. Noncoding RNAs as Promising Diagnostic Biomarkers and Therapeutic Targets in Intestinal Fibrosis of Crohn’s Disease: The Path From Bench to BedsideInflammatory Bowel Diseases 2021; 27(7): 971 doi: 10.1093/ibd/izaa321
21
Yifei Wang, Bin Huang, Tao Jin, Dickson Kofi Wiredu Ocansey, Jiajia Jiang, Fei Mao. Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem Cell TherapyFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.835005